Carregant...

Novel Targeting of Phoshatidylinositol-3 Kinase and Mammalian Target of Rapamycin (mTOR) in Renal Cell Carcinoma

Allosteric inhibitors of the kinase mammalian target of rapamycin (mTOR) have demonstrated significant clinical activity in patients with advanced renal cell carcinoma (RCC). Unfortunately, substantial clinical responses to these rapalogues are only seen in a subset of patients with advanced RCC. Pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Cho, Daniel
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934425/
https://ncbi.nlm.nih.gov/pubmed/23867512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31829d5cea
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!